Other Species / Isoforms
  USF1 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T153
EALLGQATPPSTGQF
4 1
USF1 (human) EALLGQAtPPGTGQF T153-p
USF1 (mouse) EALLGQATPPSTGQF T153
USF1 (rat) EALLGQATPPSTGQF T153
S186-p
APRTHPYsPKSEAPR
Upstream
1 19
Treatment
  • ischemia
USF1 (human) APRTHPYsPKsEAPR S186-p
USF1 (mouse) APRTHPYsPKSEAPR S186-p
USF1 (rat) APRTHPYSPKSEAPR S186
S189
THPYsPKSEAPRTTR
0 1
USF1 (human) THPYsPKsEAPRTTR S189-p
USF1 (mouse) THPYsPKSEAPRTTR S189
USF1 (rat) THPYSPKSEAPRTTR S189
K199
PRTTRDEKRRAQHNE
1 0
USF1 (human) PRTTRDEkRRAQHNE K199-ac
USF1 (mouse) PRTTRDEKRRAQHNE K199
USF1 (rat) PRTTRDEKRRAQHNE K199
K214-ub
VERRRRDkINNWIVQ
0 4
USF1 (human) VERRRRDkINNWIVQ K214-ub
USF1 (mouse) VERRRRDkINNWIVQ K214-ub
USF1 (rat) VERRRRDKINNWIVQ K214
K235-ac
DCSMESTkSGQSKGG
Upstream
Downstream
2 1
Effects on Biological Processes:
  • transcription, altered
Treatment
  • insulin
  • meal feeding
USF1 (human) DCSMESTkSGQSkGG K235-ac
USF1 (mouse) DCSMESTkSGQSKGG K235-ac
USF1 (rat) DCSMESTKSGQSKGG K235
K235
DCSMESTKSGQSKGG
0 3
USF1 (human) DCSMESTkSGQSkGG K235-ub
USF1 (mouse) DCSMESTKSGQSKGG K235
USF1 (rat) DCSMESTKSGQSKGG K235
K240
STkSGQSKGGILSKA
0 1
USF1 (human) STkSGQSkGGILSkA K240-ub
USF1 (mouse) STkSGQSKGGILSKA K240
USF1 (rat) STKSGQSKGGILSKA K240
K246
SKGGILSKACDYIQE
0 2
USF1 (human) SkGGILSkACDYIQE K246-ub
USF1 (mouse) SKGGILSKACDYIQE K246
USF1 (rat) SKGGILSKACDYIQE K246
S262-p
RQSNHRLsEELQGLD
Upstream
Downstream
2 1
Effects on Modified Protein
  • acetylation
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • DNAPK (human)
Putative in vivo kinases:
  • DNAPK (human)
Treatment
  • insulin
  • meal feeding
  • okadaic_acid
  • siRNA
  • tautomycin
view more >
USF1 (human) RQSNHRLsEELQGLD S262-p
USF1 (mouse) RQSNHRLsEELQGLD S262-p
USF1 (rat) RQSNHRLSEELQGLD S262
K286
RQQVEDLKNKNLLLR
0 1
USF1 (human) RQQVEDLkNkNLLLR K286-ub
USF1 (mouse) RQQVEDLKNKNLLLR K286
USF1 (rat) RQQVEDLKNKNLLLR K286
K288
QVEDLKNKNLLLRAQ
0 1
USF1 (human) QVEDLkNkNLLLRAQ K288-ub
USF1 (mouse) QVEDLKNKNLLLRAQ K288
USF1 (rat) QVEDLKNKNLLLRAQ K288
K288
QVEDLKNKNLLLRAQ
0 1
USF1 (human) QVEDLkNkNLLLRAQ K288-sm
USF1 (mouse) QVEDLKNKNLLLRAQ K288
USF1 (rat) QVEDLKNKNLLLRAQ K288
K306
HGLEVVIKNDsN___
0 1
USF1 (human) HGLEVVIkNDsN___ K306-sm
USF1 (mouse) HGLEVVIKNDsN___ K306
USF1 (rat) HGLEVVIKNDSN___ K306
S309-p
EVVIKNDsN______
Upstream
Downstream
1 5
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, inhibited
Putative upstream phosphatases:
  • PTP4A1 (human)
Treatment
  • insulin
  • MK-2206
USF1 (human) EVVIkNDsN______ S309-p
USF1 (mouse) EVVIKNDsN______ S309-p
USF1 (rat) EVVIKNDSN______ S309